Eli Lilly Indianapolis

Eli Lilly’s earnings, shares lifted by obesity drug sales

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for its weight loss medicines in January.

The Associated Press - Busines… · 1d

Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker debuted a mostly better-than-expected 2025 forecast.

The Financial Times · 1d

Eli Lilly expects to beat profit forecasts on obesity drug demand

The world’s biggest drugmaker Eli Lilly has forecast that profits for the year will beat expectations, after two choppy quarters when disappointing sales of its blockbuster weight-loss drugs led to sharp sell-offs in its shares.

Reuters on MSN · 1d

Lilly forecasts 2025 profit growth after recent weight-loss drug worries

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, providing some relief to investors after another quarter of sales miss for its popular diabetes and weight-loss treatments.

CNBC on MSN · 1d

Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.

13hon MSN

Eli Lilly's rating gets an upgrade to Aa3 by Moody's Ratings

Ratings has upgraded the issuer rating and senior unsecured notes ratings of global pharmaceutical company Eli Lilly and ...

Lilly reassures investors that weight-loss drug demand is strong, shares rise

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...

Ibj.com1d

Lilly reports robust Q4, full-year earnings

Lilly's fourth-quarter earnings, released before the market opened Thursday, surpassed analysts' expectations by millions.

FiercePharma1d

Eli Lilly logs massive Q4 revenue jump—but it's not just thanks to Mounjaro and Zepbound

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of ...

Hosted on MSN1d

What Are Wall Street Analysts' Target Price for Eli Lilly Stock?

With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global ...

BizTimes12d

Eli Lilly’s planned $3 billion investment in Pleasant Prairie called a ‘watershed moment’ for local economy

On an investment spree with billions of dollars’ worth of projects ongoing globally, Indianapolis-based Eli Lilly and Company ...

Lilly: Q4 Earnings Snapshot

Eli Lilly and Co. (LLY) on Thursday reported fourth-quarter earnings of $4.41 billion. The Indianapolis-based company said it had profit of $4.88 per share.

Eli Lilly Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Analysts expect the Indianapolis, Indiana-based company to report quarterly earnings at $5.08 per share, up from $2.49 per ...

Ibj.com9d

Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

Daily3d

Lilly India names Winselow Tucker as President, General Manager

Eli Lilly and Company has announced the appointment of Winselow Tucker as President and General Manager for Lilly India, ...

1don MSN

Here’s Why Eli Lilly (LLY) Traded Down in Q4

Fred Alger Management, an investment management company, released its “Alger Spectra Fund” fourth quarter 2024 investor ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results